Current News

	Search for:		in:

Target:

Full text

Title

Company name

Division:

Country:

From:

To:

Operation:		OR		AND
Search for:		partial		exact

Overview

Companies

Countries

Oncolytics Biotech Inc. Announces Issuance of Patent for Treatment of Cellular Proliferative Disorders

09 Aug 2007 - Oncolytics Biotech Inc. today announced that it has been granted U.S. Patent 7,252,817 entitled "Viruses for the Treatment of Cellular Proliferative Disorders." The claims cover the use of modified herpes simplex viruses (HSV) to treat cellular proliferative disorders which include neoplasias (cancers).

�
"This patent expands our intellectual property portfolio in viruses other than reovirus," said Dr. Matt Coffey, Chief Scientific Officer of Oncolytics.

�

Additional information

Oncolytics Biotech Inc
Calgary, AB, Canada

Company

Buyer's Guide entry of Oncolytics Biotech Inc

�

News

	04 Sep 2008 -	Oncolytics Biotech Inc. Announces U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients
	13 Aug 2008 -	Oncolytics Biotech Inc. Completes Dose Escalation in Combination REOLYSIN/Docetaxel Trial
	16 May 2008 -	Oncolytics Biotech Announces U.K. Phase II Clinical Trial Investigating REOLYSIN in Combination with Paclitaxel and Carboplatin
�more news